Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Clinical Gastroenterology and Hepatology - United Kingdom
doi 10.1016/j.cgh.2016.08.044
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy

International Journal of Rheumatic Diseases
Rheumatology
2016English

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Association Between Serum Tumor Necrosis Factor-Alpha Level and the Efficacy of Infliximab for Refractory Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis

Journal of the Anus, Rectum and Colon
2017English

Letter: Comparative Efficacy of Biological Therapy in Patients With Ulcerative Colitis - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2014English

Tumor Necrosis Factor Α Antagonists in the Treatment of the Patients With Rheumatoid Arthritis

Reumatologia
RheumatologyAllergyImmunology
2012English

Vedolizumab Exposure Levels and Clinical Outcomes in Ulcerative Colitis: Determining the Potential for Dose Optimisation

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Corrigendum: Tofacitinib Induction and Maintenance Therapy in East Asian Patients With Active Ulcerative Colitis: Subgroup Analyses From Three Phase 3 Multinational Studies

Intestinal Research
Gastroenterology
2018English

Efficacy of Tacrolimus for Induction of Remission in Patients With Moderate-To-Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis

Arquivos de Gastroenterologia
Gastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy